TNeuro’s platform is based on research from Christopher Wheeler, TNeuroPharma’s chief science officer, which started when he was working for Cedars-Sinai in Los Angeles.
Source: The Business Journal
New Mexico biotechnology company receives investment for Alzheimer's blood test
Published in Polvadera
More from PolvaderaMore posts in Polvadera »
- Schools, senior centers & farmers honored for promoting <b>New Mexico</b>-grown food
- 9 Of The Friendliest Towns In <b>New Mexico</b> – World Atlas
- <b>New Mexico</b> agribusinesses receive federal funding for mid-supply chain operations
- <b>New Mexico</b> grants $3.54M to boost local food supply chain | KTSM 9 News
- Cincinnati faces <b>New Mexico</b> – AP News
Be First to Comment